Transcatheter Aortic Valve Implantation (TAVI) is an interventional procedure for the treatment of aortic stenosis. The Transcatheter Aortic Valve Implantation Registry (TAVI-R), based at SAHMRI, was established in 2018 as a clinical quality registry, supported by ACOR Ltd. ACOR recognises the critical importance of a national cardiovascular clinical quality registry that captures data on the quality, safety, and appropriateness of transcatheter aortic valve replacement procedures. The registry collects a defined dataset encompassing patient characteristics, procedural techniques, device information, and patient outcomes.
SAHMRI and ACOR collaborate closely to manage and maintain the registry for TAVI procedures across Australia. With the support of TAVI-performing hospitals, clinicians, and device companies, the registry facilitates continuous monitoring of procedural and device safety, while also supporting research initiatives aimed at advancing patient care.
All hospitals performing TAVI procedures are eligible to contribute data to the registry. It is a requirement to be accredited for TAVI should the practitioner wish to bill Medicare.
The TAVI Registry aims to:
- Improve patient care and outcomes
- Educate clinicians and healthcare providers
- Identify areas of excellence and opportunities for improvement
- Ensure sites and clinicians meet the accreditation requirements to undertake TAVI procedures
- Provide an accurate and transparent assessment of the safety of the TAVI procedure and devices